Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 20846199)

1.

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study.

Karagianis J, Landry J, Hoffmann VP, Grossman L, de Haan L, Maguire G, Milev R, Holt S.

Int J Clin Pract. 2010 Oct;64(11):1520-9. doi: 10.1111/j.1742-1241.2010.02485.x.

PMID:
20846199
2.

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.

Karagianis J, Grossman L, Landry J, Reed VA, de Haan L, Maguire GA, Hoffmann VP, Milev R.

Schizophr Res. 2009 Aug;113(1):41-8. doi: 10.1016/j.schres.2009.05.024. Epub 2009 Jun 16. Erratum in: Schizophr Res. 2011 Dec;133(1-3):266.

PMID:
19535229
3.

Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.

Arranz B, San L, Dueñas RM, Centeno M, Ramirez N, Salavert J, Del Moral E.

Hum Psychopharmacol. 2007 Jan;22(1):11-5.

PMID:
17191265
4.

Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.

Crocq MA, Guillon MS, Bailey PE, Provost D.

Eur Psychiatry. 2007 Oct;22(7):453-4. Epub 2007 Aug 30.

PMID:
17761403
5.
7.

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Feb;62(2):92-100.

PMID:
11247108
8.

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.

Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.

J Clin Psychiatry. 2008 Nov;69(11):1776-89. Epub 2008 Oct 7.

PMID:
19014751
9.

Weight loss during therapy with olanzapine orally disintegrating tablets: two case reports.

Kozumplik O, Uzun S, Jakovljević M.

Psychiatr Danub. 2009 Mar;21(1):72-4.

10.

Weight gain during treatment of bipolar I patients with olanzapine.

Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2004 Dec;65(12):1679-87.

PMID:
15641874
11.

A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.

McElroy SL, Winstanley E, Mori N, Martens B, McCoy J, Moeller D, Guerdjikova AI, Keck PE Jr.

J Clin Psychopharmacol. 2012 Apr;32(2):165-72. doi: 10.1097/JCP.0b013e3182488758.

PMID:
22367654
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
13.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
14.

Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.

Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L, Chawla B.

Hum Psychopharmacol. 2008 Jun;23(4):275-81. doi: 10.1002/hup.933. Review.

PMID:
18338426
15.

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2000 Sep;57(9):841-9. Erratum in: Arch Gen Psychiatry 2002 Jan;59(1):91.

PMID:
10986547
16.

Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.

Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C.

J Clin Psychiatry. 2006 Apr;67(4):547-53.

PMID:
16669719
17.

Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.

Simpson MM, Goetz RR, Devlin MJ, Goetz SA, Walsh BT.

J Clin Psychiatry. 2001 Sep;62(9):694-700.

PMID:
11681765
18.

Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.

Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B.

J Clin Psychiatry. 2006 Aug;67(8):1253-60.

PMID:
16965204
19.

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Apr;62(4):231-8.

PMID:
11379836
20.

Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.

Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C.

Bipolar Disord. 2010 Mar;12(2):172-84. doi: 10.1111/j.1399-5618.2010.00797.x.

PMID:
20402710
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk